Conducting indirect-treatment-comparison and network-meta-analysis studies: report of the ISPOR Task Force on Indirect Treatment Comparisons Good Research Practices: part 2. Read more about Conducting indirect-treatment-comparison and network-meta-analysis studies: report of the ISPOR Task Force on Indirect Treatment Comparisons Good Research Practices: part 2.
An economic evaluation of short-acting opioids for treatment of breakthrough pain in patients with cancer. Read more about An economic evaluation of short-acting opioids for treatment of breakthrough pain in patients with cancer.
Cost-effectiveness evaluation of ertapenem versus piperacillin/tazobactam in the treatment of complicated intraabdominal infections accounting for antibiotic resistance. Read more about Cost-effectiveness evaluation of ertapenem versus piperacillin/tazobactam in the treatment of complicated intraabdominal infections accounting for antibiotic resistance.
Economic evaluation of caspofungin versus liposomal amphotericin B for empiric antifungal treatment in patients with neutropenic fever in Italy. Read more about Economic evaluation of caspofungin versus liposomal amphotericin B for empiric antifungal treatment in patients with neutropenic fever in Italy.
Bayesian meta-analysis of multiple treatment comparisons: an introduction to mixed treatment comparisons. Read more about Bayesian meta-analysis of multiple treatment comparisons: an introduction to mixed treatment comparisons.
Assessing productivity loss and activity impairment in severe or difficult-to-treat asthma. Read more about Assessing productivity loss and activity impairment in severe or difficult-to-treat asthma.
Measuring patient preferences for colorectal cancer screening using a choice-format survey. Read more about Measuring patient preferences for colorectal cancer screening using a choice-format survey.
Economic evaluation of voriconazole versus conventional amphotericin B in the treatment of invasive aspergillosis in Germany. Read more about Economic evaluation of voriconazole versus conventional amphotericin B in the treatment of invasive aspergillosis in Germany.
